AI Improves Early Detection of Cardiac Amyloidosis in Patients Ultromics' recent study reveals AI's potential in identifying cardiac amyloidosis earlier, enhancing patient outcomes significantly with accurate echocardiography analysis.

AI Improves Early Detection of Cardiac Amyloidosis in Patients #United_Kingdom #Oxford #Ultromics #EchoGo #Cardiac_Amyloidosis

Ultromics' EchoGo® Amyloidosis Revolutionizes Cardiac Amyloidosis Detection with AI A new study showcases Ultromics' EchoGo® Amyloidosis, an AI tool that significantly enhances the detection of cardiac amyloidosis, facilitating timely diagnosis.

Ultromics' EchoGo® Amyloidosis Revolutionizes Cardiac Amyloidosis Detection with AI #United_Kingdom #Oxford #AI_Tool #Ultromics #EchoGo

Ultromics Unveils Groundbreaking AI Tool for Enhanced HFpEF Diagnosis with EchoGo® Heart Failure Ultromics has introduced a revolutionizing AI-powered probability scoring system for EchoGo® Heart Failure aimed at improving HFpEF diagnosis accuracy and patient management.

Ultromics Unveils Groundbreaking AI Tool for Enhanced HFpEF Diagnosis with EchoGo® Heart Failure #United_Kingdom #Oxford #HFpEF #Ultromics #EchoGo

We’re excited to share our latest research & innovation at several events this year. Ultromics is transforming cardiology with advanced AI that supports #HFpEF and Cardiac #Amyloidosis detection. Upcoming events: www.ultromics.com/about/events #EchoGo #MedSky #CardioSky